Humankind Investments LLC Sells 21,519 Shares of Procter & Gamble Company (The) $PG

13 Dec 2025, 10:36 by Scott Moore · The Cerbat Gem

Humankind Investments LLC lessened its stake in shares of Procter & Gamble Company (The) (NYSE:PG – Free Report) by 57.4% in the 2nd quarter, according to its most recent disclosure with the SEC. The firm owned 15,996 shares of the company’s stock after selling 21,519 shares during the period. Procter & Gamble accounts for about 0.6% of Humankind Investments LLC’s investment portfolio, making the stock its 23rd biggest holding. Humankind Investments LLC’s holdings in Procter & Gamble were worth $2,548,000 as of its most recent filing with the SEC.

Other institutional investors have also recently made changes to their positions in the company. Kingstone Capital Partners Texas LLC boosted its position in shares of Procter & Gamble by 655,209.0% in the second quarter. Kingstone Capital Partners Texas LLC now owns 76,028,952 shares of the company’s stock worth $11,832,680,000 after purchasing an additional 76,017,350 shares during the period. Norges Bank purchased a new position in shares of Procter & Gamble during the 2nd quarter valued at $5,099,644,000. Laurel Wealth Advisors LLC boosted its holdings in Procter & Gamble by 15,971.7% in the 2nd quarter. Laurel Wealth Advisors LLC now owns 7,012,744 shares of the company’s stock worth $1,117,270,000 after buying an additional 6,969,110 shares during the period. Vanguard Group Inc. increased its stake in Procter & Gamble by 1.4% in the 2nd quarter. Vanguard Group Inc. now owns 233,211,283 shares of the company’s stock worth $37,155,222,000 after buying an additional 3,189,111 shares in the last quarter. Finally, Invesco Ltd. raised its holdings in Procter & Gamble by 21.4% during the second quarter. Invesco Ltd. now owns 16,374,499 shares of the company’s stock valued at $2,608,785,000 after acquiring an additional 2,880,895 shares during the period. Institutional investors own 65.77% of the company’s stock.

Insider Buying and Selling

In other Procter & Gamble news, CEO Jon R. Moeller sold 11,684 shares of the business’s stock in a transaction that occurred on Thursday, October 2nd. The stock was sold at an average price of $152.23, for a total transaction of $1,778,655.32. Following the sale, the chief executive officer directly owned 319,932 shares of the company’s stock, valued at $48,703,248.36. The trade was a 3.52% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available through this link. Also, CEO Gary A. Coombe sold 3,535 shares of the firm’s stock in a transaction that occurred on Thursday, October 2nd. The shares were sold at an average price of $152.23, for a total value of $538,133.05. Following the completion of the sale, the chief executive officer directly owned 34,816 shares of the company’s stock, valued at $5,300,039.68. The trade was a 9.22% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders have sold a total of 30,308 shares of company stock valued at $4,611,852 in the last quarter. 0.20% of the stock is currently owned by insiders.

Analysts Set New Price Targets

A number of research firms have recently weighed in on PG. Deutsche Bank Aktiengesellschaft dropped their price objective on Procter & Gamble from $176.00 to $171.00 and set a “buy” rating for the company in a research note on Monday, December 8th. BNP Paribas restated an “outperform” rating and issued a $177.00 price target on shares of Procter & Gamble in a research note on Friday, August 15th. JPMorgan Chase & Co. lifted their price objective on shares of Procter & Gamble from $163.00 to $165.00 and gave the company a “neutral” rating in a research report on Monday, October 27th. Berenberg Bank boosted their target price on shares of Procter & Gamble from $152.00 to $154.00 and gave the stock a “hold” rating in a report on Wednesday, September 17th. Finally, Morgan Stanley set a $175.00 target price on shares of Procter & Gamble in a research note on Monday, October 27th. Twelve analysts have rated the stock with a Buy rating and ten have assigned a Hold rating to the stock. According to MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus target price of $171.40.

Get Our Latest Research Report on PG

Procter & Gamble Stock Up 1.4%

NYSE PG opened at $142.77 on Friday. The stock has a 50 day moving average price of $147.84 and a 200-day moving average price of $154.34. Procter & Gamble Company has a one year low of $138.14 and a one year high of $179.99. The company has a debt-to-equity ratio of 0.46, a quick ratio of 0.51 and a current ratio of 0.71. The company has a market capitalization of $333.61 billion, a P/E ratio of 20.84, a P/E/G ratio of 4.73 and a beta of 0.39.

Procter & Gamble (NYSE:PG – Get Free Report) last released its quarterly earnings results on Friday, October 24th. The company reported $1.99 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.90 by $0.09. Procter & Gamble had a net margin of 19.74% and a return on equity of 32.63%. The company had revenue of $22.39 billion for the quarter, compared to the consensus estimate of $22.23 billion. During the same quarter in the prior year, the firm earned $1.93 earnings per share. Procter & Gamble’s revenue was up 3.0% on a year-over-year basis. Procter & Gamble has set its FY 2026 guidance at 6.830-7.100 EPS. As a group, equities analysts predict that Procter & Gamble Company will post 6.91 EPS for the current fiscal year.

Procter & Gamble Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Monday, November 17th. Investors of record on Friday, October 24th were issued a $1.0568 dividend. The ex-dividend date of this dividend was Friday, October 24th. This represents a $4.23 dividend on an annualized basis and a dividend yield of 3.0%. Procter & Gamble’s dividend payout ratio (DPR) is presently 61.75%.

About Procter & Gamble

(Free Report)